Functional interactions between P-glycoprotein and CYP3A in drug metabolism

By Christians Uwe   Schmitz Volker   Haschke Manuel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 641-654

Informa Healthcare

Access to resources Recommend Favorite

Phase II Drug Metabolism and Individualized Drug Therapy: A Focus on Functional Genetic Variation in UDP-Glucuronosyltransferases

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 2, 2010-06 ,pp. : 146-166

Bentham Science Publishers

Access to resources Recommend Favorite

Drug metabolism and drug toxicity

By Park B. Kevin   Kitteringham Neil R.   Kenny Jane R.   Pirmohamed Munir  

Inflammopharmacology, Vol. 9, Iss. 1-2, 2001-05 ,pp. : 183-199

VSP

Access to resources Recommend Favorite

Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation

By Kang Myung J.   Kim Bo G.   Eum Jae Y.   Park Sang H.   Choi Sun E.   An Jae J.   Jang Sang H.   Eum Won S.   Lee Jaehwi   Lee Min W.   Kang Kyungho   Oh Chil H.   Choi Soo Y.   Choi Young W.  

Journal of Drug Targeting, Vol. 19, Iss. 7, 2011-08 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

The Functional Role of CYP2B6 in Human Drug Metabolism: Substrates and Inhibitors In Vitro, In Vivo and In Silico

By  

Current Drug Metabolism, Vol. 7, Iss. 7, 2006-10 ,pp. : 705-714

Bentham Science Publishers

Access to resources Recommend Favorite